Global Pharmaceutical Giant AstraZeneca Gains Vital Market Insights, New Efficiencies with MicroStrategy Business Intelligence
AstraZeneca Employs Platform for Rapid Sales Information
McLean, Va., (January 08, 2002) –
MicroStrategy® Incorporated (NASDAQ: MSTR), a leading worldwide provider of business intelligence software, today announced that London-based AstraZeneca (NYSE:AZN) is using the MicroStrategy Business Intelligence Platform(TM) to anchor its sales prescriber data warehouse (SPW). Approximately 250 employees use MicroStrategy’s Web-based analytical tools to determine market share, easily explore cost and profit data, and track the performance of new products. As a result, employees are making more effective business decisions that increase sales and drive market share gains.
AstraZeneca, a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services, is one of the top five pharmaceutical companies in the world with healthcare sales of $15.8 billion. The global pharmaceutical company uses the MicroStrategy platform to distribute 70,000 reports within a 24-hour window each month. AstraZeneca employees can pull up reports through its salesforce portal or run queries, with 20-second average response times, against a one-terabyte Oracle® data warehouse. As a result, end users can view critical pharmaceutical sales information in a matter of seconds and quickly make decisions that seek to optimize market share with a particular HMO or prescription benefit management organization.
“MicroStrategy business intelligence gives us a better understanding of the market, and helps us meet expected market share goals for our products,” said Keith Megay, senior manager of commercial data warehousing at AstraZeneca. “In addition, the performance and scalability of our MicroStrategy-based application is remarkable, allowing our users to be more productive and efficient.”
About AstraZeneca
AstraZeneca (NYSE:AZN) is a major international healthcare business engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of $15.8 billion and leading positions in sales of gastrointestinal, oncology, anesthesia (including pain management), cardiovascular, central nervous system (CNS) and respiratory products. In the United States, AstraZeneca is an $8 billion healthcare business with more than 10,000 employees. For more information about AstraZeneca please visit www.astrazeneca-us.com
About MicroStrategy Incorporated
Leadership in a Critical Market: Founded in 1989, MicroStrategy is a worldwide leader in the critical business intelligence software market. Large and small companies alike are harnessing MicroStrategy’s business intelligence software to gain vital insights from their data to help them proactively enhance cost-efficiency, productivity and customer relations and optimize revenue-generating strategies. MicroStrategy’s business intelligence platform offers exceptional capabilities that provide organizations — in virtually all facets of their operations — with user-friendly solutions to their data query, reporting, and advanced analytical needs, and distributes valuable insight on this data to users via Web, wireless, and voice. PC Magazine recently selected MicroStrategy 7(TM) as the 2001 “Editors’ Choice” for business intelligence software.
Built for the Internet: MicroStrategy 7 is the Scalable Business Intelligence Platform Built for the Internet(TM). Its pure-Web architecture provides Web reporting, security, performance and standards that are critical for Web deployment. Within intranets, MicroStrategy’s products provide employees with information to enable them to make better, more cost-effective business decisions. In extranets, enterprises can use MicroStrategy 7 to build stronger relationships by linking customers and suppliers via the Internet.
Diverse Customer Base: MicroStrategy’s customer base cuts across industry and sector lines, with approximately 1,500 enterprise-class customers, including Lowe’s Home Improvement Warehouse, AT&T Wireless Group, Wachovia and GlaxoSmithKline. MicroStrategy also has relationships with over 400 systems integrators and application development and platform partners, including IBM, PeopleSoft, Compaq, Informatica and JD Edwards.
MicroStrategy is listed on Nasdaq under the symbol MSTR. For more information on the company, or to purchase or demo MicroStrategy’s software, please visit MicroStrategy’s Web site at http://www.microstrategy.com.
This press release may include statements that may constitute “forward-looking statements,” including its estimates of future business prospects or financial results and statements containing the words “believe,” “estimate,” “project,” “expect” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results of MicroStrategy Incorporated and its subsidiaries (collectively, the “Company”) to differ materially from the forward-looking statements. Factors that could contribute to such differences include: the possibility that the conditions to the securities class action and shareholder derivative settlement agreements will not be satisfied; the Company’s ability to secure financing for its current operations and long-term plans on acceptable terms; the ability of the Company to implement and achieve widespread customer acceptance of its MicroStrategy 7 software on a timely basis; the Company’s ability to recognize deferred revenue through delivery of products or satisfactory performance of services; continued acceptance of the Company’s products in the marketplace; the timing of significant orders; delays in the Company’s ability to develop or ship new products; market acceptance of new products; competitive factors; general economic conditions; currency fluctuations and other risks detailed in the Company’s registration statements and periodic reports filed with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
MicroStrategy, MicroStrategy Business Intelligence Platform, MicroStrategy 7, Scalable Business Intelligence Platform Built for the Internet, MicroStrategy Web are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.
Claudia Cahill
MicroStrategy Incorporated
(703) 848-8600
pr_info@microstrategy.com
Source: MicroStrategy